Prevalence of Sleep Apnea Syndrome in patients with stable Chronic Heart Failure in the Dutch population

Prevalence of Sleep Apnea Syndrome in patients with stable Chronic Heart Failure in the Dutch population - SAS in CHF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35928

Enrollment

100

Registered

2011-06-24

Start date

2011-07-14

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep apnea sleep apnea syndrome (SAS)

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: •Patients with NYHA functional class II-IV stable heart failure for at least 3 months •Patients able to understand the procedures and are willing to provide informed consent

Exclusion criteria

Exclusion criteria: •Patients aged

Design outcomes

Secondary

Measure	Time frame
From online medical patient*s files: Echocardiographic parameters (i.e. left ventricular ejection fraction), Parameters of the bicycle ergometric cardiopulmonary exercise test (Peak VO2), Routine blood measurements (e.g. hemoglobin-level, NT-proBNP). Additional measurements: ApneaLink, Blood sample assessment, Urine sample assessment, Excessive Daytime Sleepiness (EDS).	—

Primary

Measure	Time frame
Percentage of CHF-patients without SAS, and percentage of CHF-patients with SAS (OSAS and CSAS). Therefore, apnea-hypopnea index (AHI) will be measured by polysomnography.	—

Countries

Netherlands

Outcome results